Überörtliche Gemeinschaftspraxis Schwerpunkt Haematologie, internistische Onkologie&Palliativmedizin
- Address
- Hohe Weide 17 b, 20259 Hamburg, Germany
Überörtliche Gemeinschaftspraxis Schwerpunkt Hämatologie, Internistische Onkologie & Palliativmedizin
This specialized oncology practice focuses on comprehensive cancer care with expertise in hematology, internal medicine oncology, and palliative medicine. The center actively participates in cutting-edge clinical research investigating novel therapeutic approaches for both solid tumors and hematologic malignancies, with particular emphasis on personalized treatment strategies and disease-free survival optimization.
- Hormone receptor-positive breast cancer research, including adjuvant endocrine therapy trials with targeted agents like ribociclib and camizestrant
- Locally advanced rectal cancer treatment optimization, evaluating risk-adapted chemotherapy strategies and timing of intervention
- Precision oncology approaches utilizing biomarker-guided therapy selection and dynamic treatment adaptation
The practice demonstrates significant expertise in early breast cancer management, particularly in ER+/HER2- subtypes, where they investigate both standard-of-care comparisons and extended adjuvant therapy regimens. Their involvement in gastrointestinal oncology trials reflects a commitment to improving outcomes in colorectal malignancies through innovative perioperative treatment approaches. The center's comprehensive focus on internal medicine oncology enables them to provide holistic cancer care while advancing clinical research in multiple therapeutic areas.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 19 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1AstraZeneca AB1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Überörtliche Gemeinschaftspraxis Schwerpunkt Haematologie, internistische Onkologie&Palliativmedizin
lock Showing 1 of 2 trials — the rest is available on a paid plan.
IMP list
lock Showing 1 of 19 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Anastrozole | 1 | Unknown | 2023-07-25 | 2023-07-25 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.